Fesarius Therapeutics
Updated: August 08, 2026
The team
Country: USA | Funding: $22.6M (+)
Founded: 2015
Website: https://www.fesariustherapeutics.com/
Fesarius Therapeutics is focused on dermal repair. Its lead product, DermiSphere hDRT, is FDA-cleared hydrogel dermal regeneration template designed for wound management. It's as a dual-density collagen hydrogel template that supports cellular invasion and vascularized tissue regeneration. The company said also develops OneStep procedure that DermiSphere and a split-thickness skin graft to be applied simultaneously and thus reduce recovery time, pain and total cost of care (in comparison with current two-stage approach for some full-thickness skin-loss cases, when a surgeon places a dermal substitute in one procedure, and then the patient returns for a second surgery after the template has vascularized enough to support a skin graft).
Founded: 2015
Website: https://www.fesariustherapeutics.com/
Fesarius Therapeutics is focused on dermal repair. Its lead product, DermiSphere hDRT, is FDA-cleared hydrogel dermal regeneration template designed for wound management. It's as a dual-density collagen hydrogel template that supports cellular invasion and vascularized tissue regeneration. The company said also develops OneStep procedure that DermiSphere and a split-thickness skin graft to be applied simultaneously and thus reduce recovery time, pain and total cost of care (in comparison with current two-stage approach for some full-thickness skin-loss cases, when a surgeon places a dermal substitute in one procedure, and then the patient returns for a second surgery after the template has vascularized enough to support a skin graft).
